The chromatin remodeling protein CHD7, mutated in CHARGE syndrome, is necessary for proper craniofacial and tracheal development

Developmental Dynamics

Volumn 243, Issue 9, 2014, Pages 1055-1066

  Sperry, Ethan D ^a,b   Hurd, Elizabeth A ^c   Durham, Mark A ^a   Reamer, Elyse N ^a   Stein, Adam B ^a   Martin, Donna M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cleft palate; Craniofacial disorders; Skeletal dysplasia; Trachea

Indexed keywords

CELL PROTEIN; CHD7 PROTEIN; CRE RECOMBINASE; UNCLASSIFIED DRUG; WNT1 PROTEIN; CHD7 PROTEIN, MOUSE; DNA BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE DYSPLASIA; CELL MIGRATION; CLEFT PALATE; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; DEATH; DISEASE SEVERITY; DYSPLASIA; EAR DEVELOPMENT; EYE DEVELOPMENT; EYE DYSPLASIA; FOREBRAIN DEVELOPMENT; FRONTAL BONE; GENE DELETION; HETEROZYGOTE; INTESTINE DEVELOPMENT; LIMB MALFORMATION; MANDIBLE HYPOPLASIA; MAXILLA HYPOPLASIA; MOUSE; NEURAL CREST; NEURAL CREST CELL; NONHUMAN; NOSE DEVELOPMENT; NOSE MUCOSA; ORGANOGENESIS; PHARYNGEAL POUCH DEVELOPMENT; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SYNDROME CHARGE; TRACHEAL DEVELOPMENT; ABNORMALITIES; ANIMAL; CRANIOFACIAL MALFORMATION; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MULTIPLE MALFORMATION SYNDROME; TRACHEA;

ABNORMALITIES, MULTIPLE; ANIMALS; CHARGE SYNDROME; CRANIOFACIAL ABNORMALITIES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, KNOCKOUT; TRACHEA;

EID: 84906315154     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.24156     Document Type: Article

References (49)

1. Adams ME, Hurd EA, Beyer LA, Swiderski DL, Raphael Y, Martin DM. 2007. Defects in vestibular sensory epithelia and innervation in mice with loss of Chd7 function: implications for human CHARGE syndrome. J Comp Neurol 504:519-532.
2. Akisu M, Ozkinay F, Ozyurek R, Kucuktas A, Kultursay N. 1998. The CHARGE association in a newborn infant. Turk J Pediatr 40:283-287.
3. Bajpai R, Chen DA, Rada-Iglesias A, Zhang J, Xiong Y, Helms J, Chang CP, Zhao Y, Swigut T, Wysocka J. 2010. CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature 463:958-962.
4. Bergman JEH, Bosman EA, van Ravenswaaij-Arts CMA, Steel KP. 2010. Study of smell and reproductive organs in a mouse model for CHARGE syndrome. Eur J Hum Genet 18:171-177.
5. Bergman JEH, Janssen N, Hoefsloot LH, Jongmans MCJ, Hofstra RMW, van Ravenswaaij-Arts CMA. 2011. CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. J Med Genet 48:334-342.
6. Bosman EA, Penn AC, Ambrose JC, Kettleborough R, Stemple DL, Steel KP. 2005. Multiple mutations in mouse Chd7 provide models for CHARGE syndrome. Hum Mol Genet 14:3463-3476.
7. Bush JO, Jiang R. 2012. Palatogenesis: morphogenetic and molecular mechanisms of secondary palate development. Development 139:231-243.
8. Chapman KL, Hardin-Jones MA, Goldstein JA, Halter KA, Havlik RJ, Schulte J. 2008. Timing of palatal surgery and speech outcome. Cleft Palate Craniofac J 45:297-308.
9. Coppola D, Craven B. 2014. The effects of naris occlusion on mouse nasal turbinate development. J Exp Biol 217:2044-2052.
10. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP. 1998. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 8:1323-1326.
11. Doshi J, Krawiec ME. 2007. Clinical manifestations of airway malacia in young children. J Allergy Clin Immunol 120:1276-1278.
12. Eppley BL, van Aalst JA, Robey A, Havlik RJ, Sadove AM. 2005. The spectrum of orofacial clefting. Plast Reconstr Surg 115:101e-114e.
13. Fujita K, Aida N, Asakura Y, Kurosawa K, Niwa T, Muroya K, Adachi M, Nishimura G, Inoue T. 2009. Abnormal basiocciput development in CHARGE syndrome. AJNR Am J Neuroradiol 30:629-634.
14. Grocott T, Johnson S, Bailey AP, Streit A. 2011. Neural crest cells organize the eye via TGF-beta and canonical Wnt signalling. Nat Commun 2:265.
15. Hebert JM, McConnell SK. 2000. Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures. Dev Biol 222:296-306.
16. Hughes SS, Welsh HI, Safina NP, Bejaoui K, Ardinger HH. 2014. Family history and clefting as major criteria for CHARGE syndrome. Am J Med Genet A 164A:48-53.
17. Hurd EA, Adams ME, Layman WS, Swiderski DL, Beyer LA, Halsey KE, Benson JM, Gong TW, Dolan DF, Raphael Y, Martin DM. 2011. Mature middle and inner ears express Chd7 and exhibit distinctive pathologies in a mouse model of CHARGE syndrome. Hear Res 282:184-195.
18. Hurd EA, Capers PL, Blauwkamp MN, Adams ME, Raphael Y, Poucher HK, Martin DM. 2007. Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues. Mamm Genome 18:94-104.
19. Hurd EA, Micucci JA, Reamer EN, Martin DM. 2012. Delayed fusion and altered gene expression contribute to semicircular canal defects in Chd7 deficient mice. Mech Dev 129:308-323.
20. Hurd EA, Poucher HK, Cheng K, Raphael Y, Martin DM. 2010. The ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural gene expression and neurogenesis in the inner ear. Development 137:3139-3150.
21. Husu E, Hove HD, Farholt S, Bille M, Tranebjaerg L, Vogel I, Kreiborg S. 2013. Phenotype in 18 Danish subjects with genetically verified CHARGE syndrome. Clin Genet 83:125-134.
22. Hutson MR, Kirby ML. 2007. Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. Semin Cell Dev Biol 18:101-110.
23. Jacob A, Chole RA. 2006. Survey anatomy of the paranasal sinuses in the normal mouse. Laryngoscope 116:558-563.
24. Janssen N, Bergman JE, Swertz MA, Tranebjaerg L, Lodahl M, Schoots J, Hofstra RM, van Ravenswaaij-Arts CM, Hoefsloot LH. 2012. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat 33:1149-1160.
25. Jiang X, Rowitch DH, Soriano P, McMahon AP, Sucov HM. 2000. Fate of the mammalian cardiac neural crest. Development 127:1607-1616.
26. Kastl KG, Rettinger G, Keck T. 2009. The impact of nasal surgery on air-conditioning of the nasal airways. Rhinology 47:237-241.
27. Kim KS, Choi YS, Kim HJ, Yoon JH. 2003. The risk of olfactory disturbance from conchal plate injury during ethmoidectomy. Am J Rhinol 17:307-310.
28. Layman WS, Hurd EA, Martin DM. 2011. Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome. Hum Mol Genet 20:3138-3150.
29. Layman WS, McEwen DP, Beyer LA, Lalani SR, Fernbach SD, Oh E, Swaroop A, Hegg CC, Raphael Y, Martens JR, Martin DM. 2009. Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome. Hum Mol Genet 18:1909-1923.
30. Legendre M, Gonzales M, Goudefroye G, Bilan F, Parisot P, Perez MJ, Bonniere M, Bessieres B, Martinovic J, Delezoide AL, Jossic F, Fallet-Bianco C, Bucourt M, Tantau J, Loget P, Loeuillet L, Laurent N, Leroy B, Salhi H, Bigi N, Rouleau C, Guimiot F, Quelin C, Bazin A, Alby C, Ichkou A, Gesny R, Kitzis A, Ville Y, Lyonnet S, Razavi F, Gilbert-Dussardier B, Vekemans M, Attie-Bitach T. 2012. Antenatal spectrum of CHARGE syndrome in 40 fetuses with CHD7 mutations. J Med Genet 49:698-707.
31. Li L, Lin M, Wang Y, Cserjesi P, Chen Z, Chen Y. 2011. BmprIa is required in mesenchymal tissue and has limited redundant function with BmprIb in tooth and palate development. Dev Biol 349:451-461.
32. Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, Zeng H. 2010. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13:133-140.
33. Minoux M, Rijli FM. 2010. Molecular mechanisms of cranial neural crest cell migration and patterning in craniofacial development. Development 137:2605-2621.
34. Nichols DH. 1986. Formation and distribution of neural crest mesenchyme to the first pharyngeal arch region of the mouse embryo. Am J Anat 176:221-231.
35. Patten SA, Jacobs-McDaniels NL, Zaouter C, Drapeau P, Albertson RC, Moldovan F. 2012. Role of Chd7 in zebrafish: a model for CHARGE syndrome. PLoS One 7:e31650.
36. Perl AK, Wert SE, Nagy A, Lobe CG, Whitsett JA. 2002. Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci U S A 99:10482-10487.
37. Prasad C, Quackenbush EJ, Whiteman D, Korf B. 1997. Limb anomalies in DiGeorge and CHARGE syndromes. Am J Med Genet 68:179-181.
38. Randall V, McCue K, Roberts C, Kyriakopoulou V, Beddow S, Barrett AN, Vitelli F, Prescott K, Shaw-Smith C, Devriendt K, Bosman E, Steffes G, Steel KP, Simrick S, Basson MA, Illingworth E, Scambler PJ. 2009. Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice. J Clin Invest 119:3301-3310.
39. Schnetz MP, Bartels CF, Shastri K, Balasubramanian D, Zentner GE, Balaji R, Zhang X, Song L, Wang Z, Laframboise T, Crawford GE, Scacheri PC. 2009. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res 19:590-601.
40. Sinn R, Wittbrodt J. 2013. An eye on eye development. Mech Dev 130:347-358.
41. Sperber GH. 1989. Craniofacial embryology. Great Britain: Wright.
42. Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, Youn MY, Takeyama K, Nakamura T, Mezaki Y, Takezawa S, Yogiashi Y, Kitagawa H, Yamada G, Takada S, Minami Y, Shibuya H, Matsumoto K, Kato S. 2007. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 9:1273-1285.
43. Van de Laar I, Dooijes D, Hoefsloot L, Simon M, Hoogeboom J, Devriendt K. 2007. Limb anomalies in patients with CHARGE syndrome: an expansion of the phenotype. Am J Med Genet A 143A:2712-2715.
44. Wang XX, Wang X, Li ZL, Yi B, Liang C, Jia YL, Zou BS. 2009. Anterior maxillary segmental distraction for correction of maxillary hypoplasia and dental crowding in cleft palate patients: a preliminary report. Int J Oral Maxillofac Surg 38:1237-1243.
45. Wang Y, Song L, Zhou CJ. 2011. The canonical Wnt/beta-catenin signaling pathway regulates Fgf signaling for early facial development. Dev Biol 349:250-260.
46. Woo J, Miletich I, Kim BM, Sharpe PT, Shivdasani RA. 2011. Barx1-mediated inhibition of Wnt signaling in the mouse thoracic foregut controls tracheo-esophageal septation and epithelial differentiation. PLoS One 6:e22493.
47. Wright EM, O'Connor R, Kerr BA. 2009. Radial aplasia in CHARGE syndrome: a new association. Eur J Med Genet 52:239-241.
48. Yu T, Meiners LC, Danielsen K, Wong MT, Bowler T, Reinberg D, Scambler PJ, van Ravenswaaij-Arts CM, Basson MA. 2013. Deregulated FGF and homeotic gene expression underlies cerebellar vermis hypoplasia in CHARGE syndrome. Elife 2:e01305.
49. Zentner GE, Layman WS, Martin DM, Scacheri PC. 2010. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A 152A:674-686.